RecruitingNot ApplicableNCT07605221

Nomogram for Astigmatism Correction of KLEx

Nomogram Optimization for Astigmatism Precision Correction of Corneal Refractive Correction


Sponsor

Tianjin Eye Hospital

Enrollment

100 participants

Start Date

Feb 18, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to learn if nomogram could promote treatment outcomes in astigmatism correction. The main question it aims to answer is: does the nomogram could promote treatment outcomes in astigmatism correction? If there is a comparison group: Researchers will compare non-nomogram adopted to see if the outcome acceptable. Participants will ask to complete 3-month follow-up of manifest refraction and visual acuity test.


Eligibility

Min Age: 18 YearsMax Age: 45 Years

Inclusion Criteria1

  • age ≥18 years; preoperative sphere -0.50 D to -10.00 D; preoperative cylinder -1.50 D to -5.00 D; stable refraction (±0.50 D) for 1 year; normal corneal topography; central corneal thickness >500 μm or predicted residual stromal bed >280 μm; intraocular pressure <21 mmHg

Exclusion Criteria1

  • ocular or systematic disease

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREnomogram

nomogram was added to nomogram group


Locations(1)

Tianjin Eye Hospital

Tianjin, Tianjin Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07605221


Related Trials